Search

everythinglearnresearchcommunity

for

Search:↓

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

PCOS patients have more central body fat, which can be effectively measured using DEXA.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Multimedia education greatly improves women's knowledge and management of PCOS.

Lifestyle changes improve reproductive function and hormonal balance in obese women with PCOS.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

A 16-year-old girl with HAIR-AN syndrome was treated with lifestyle changes and medications to manage her condition.

Men with type 2 diabetes often have low testosterone and signs of hypogonadism, especially if they are overweight.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

PCOS affects fertility and is linked to obesity and menstrual irregularities; lifestyle changes are recommended for treatment.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Fiber implantation for pattern baldness was largely unsuccessful with many complications and is not recommended.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.